Definitive Contract 75N93025C00031

Award Date 9/15/25
Potential Completion Date 9/14/28
Potential Value $1.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
This is a $149,543.35 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Biological Mimetics, Inc., a small business, under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I SBIR project to develop a CRISPR-based diagnostic test for parasites. The contract has a period of performance through August 30, 2016. Biological Mimetics is a biotechnology firm that provides research, development, and testing services related to infectious...
This is a $1,140,081.00 Small Business Innovation Research (STTR) Phase II contract awarded by the Defense Threat Reduction Agency to Biological Mimetics, Inc., a biotechnology company that combines biology and engineering to identify and prevent global infections. The contract is for research and development services related to infectious diseases, vaccines, diagnostics, and therapeutics. Biological Mimetics has previously received grants and contracts from federal agencies like the National...
This is a Phase II Small Business Innovation Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business headquartered in Monrovia, California. The award, valued at $1,499,763.00, is for the development of a CRISPR-based assay for portable tropical infection diagnosis (CAPTIN-D). This is a Firm Fixed Price definitive contract with a completion date of September 14, 2028. The award is...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...

This is a Phase II SBIR contract award to Biological Mimetics, Inc., a biotechnology firm in Frederick, Maryland, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $1,498,641 Firm Fixed Price contract is for the development of a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. The contract is set aside for small businesses under the SBIR program, which aims to stimulate technological innovation. Biological Mimetics, Inc. has demonstrated expertise in developing specialized diagnostic technologies through prior NIAID contract and grant awards, focusing on innovative solutions for infectious diseases and public health challenges.

Generated 9/26/25, 9:59 AM